InvestorsHub Logo
Followers 41
Posts 1693
Boards Moderated 0
Alias Born 10/19/2010

Re: michaeldouglas post# 16

Monday, 12/30/2013 3:29:26 PM

Monday, December 30, 2013 3:29:26 PM

Post# of 273
A lesson to learn with every trade.

Key here is parent company never said a PEEP about OPLI drugs as compared to all the PR's they put out about themselves as the parent company and the drug they were working on.

As Moms have said through the centuries-when you don't have anything nice to say, do not say anything.
Since they did not have anything nice to say about OPLI-they kept it to themselves up to the last minute.

Sure these results were known when they pr'ed the RA drug results earlier in the month.

Been following the work on the dry eye drug for 2 years and astounded at the results.

Read the Research paper on this drug when they were just getting into the nitty gritty lab work on this drug before they were even known on the US exchanges.

hmmm....

unsure of how the Company interpreted no Efficacy as Top Line results. Basically "well tolerated" with no benefit is just an expensive Visine eye drop!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MIGI News